Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec;24(4):205-212.
doi: 10.1080/14728214.2019.1694001.

What potential is there for LSD1 inhibitors to reach approval for AML?

Manu R Pandey  1 , Eunice S Wang  1
Affiliations
Editorial

What potential is there for LSD1 inhibitors to reach approval for AML?

Manu R Pandey et al. Expert Opin Emerg Drugs. 2019 Dec.
No abstract available

Keywords: LSD1 inhibitor; acute myeloid leukemia; clinical trial; epigenetic.

PubMed Disclaimer

References

    1. Cancer Stat Facts: Leukemia - Acute Myeloid Leukemia (AML) [7/6/2019]. Available from: https://seer.cancer.gov/statfacts/html/amyl.html
    1. Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004. May 27;429(6990):457–63. - PubMed
    1. Wouters BJ, Delwel R. Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia. Blood. 2016. January 7;127(1):42–52. - PubMed
    1. Abdel-Wahab O, Levine RL. Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia. Blood. 2013. May 2;121(18):3563–72. - PMC - PubMed
    1. Shi Y, Sawada J, Sui G, et al. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature. 2003. April 17;422(6933):735–8. - PubMed

Publication types

MeSH terms